Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors - Top-Institutions - MDSpire

Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors

  • By

  • James L. Rogers

  • Thomas Wall

  • Alvina A. Acquaye-Mallory

  • Lisa Boris

  • Yeonju Kim

  • Kenneth Aldape

  • Martha M. Quezado

  • John A. Butman

  • James G. Smirniotopoulos

  • Huma Chaudhry

  • Christina I. Tsien

  • Prashant Chittiboina

  • Kareem Zaghloul

  • Orwa Aboud

  • Nicholas G. Avgeropoulos

  • Eric C. Burton

  • David M. Cachia

  • Karan S. Dixit

  • Jan Drappatz

  • Erin M. Dunbar

  • Peter Forsyth

  • Edina Komlodi-Pasztor

  • Jacob Mandel

  • Byram H. Ozer

  • Eudocia Q. Lee

  • Surabhi Ranjan

  • Rimas V. Lukas

  • Margarita Raygada

  • Michael E. Salacz

  • Matthew A. Smith-Cohn

  • James Snyder

  • Ariane Soldatos

  • Brett J. Theeler

  • Brigitte C. Widemann

  • Kevin A. Camphausen

  • John D. Heiss

  • Terri S. Armstrong

  • Mark R. Gilbert

  • Marta Penas-Prado

  • March 1, 2024

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Neuro-Oncology
    • Molecular Diagnostics
    • Neurosurgery
    • Neuropathology

  • #2

    Memorial Sloan Kettering Cancer Center (MSKCC)
    Memorial Sloan Kettering Cancer Center (MSKCC)

    New York, NY

    Key Differentiators

    • Neuro-Oncology
    • Neurosurgery
    • Radiation Oncology
    • Neuropathology

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-Oncology
    • Neurosurgery
    • Radiation Oncology
    • Neuropathology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neuro-Oncology
    • Neurosurgery
    • Neuropathology
    • Radiation Oncology

  • #5

    Dana-Farber Cancer Institute / Brigham and Women’s Hospital
    Dana-Farber Cancer Institute / Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Neuro-Oncology
    • Neurosurgery
    • Neuropathology
    • Radiation Oncology

Original Source(s)

Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors

  • by James L. Rogers, Thomas Wall, Alvina A. Acquaye-Mallory, Lisa Boris, Yeonju Kim, Kenneth Aldape, Martha M. Quezado, John A. Butman, James G. Smirniotopoulos, Huma Chaudhry, Christina I. Tsien, Prashant Chittiboina, Kareem Zaghloul, Orwa Aboud, Nicholas G. Avgeropoulos, Eric C. Burton, David M. Cachia, Karan S. Dixit, Jan Drappatz, Erin M. Dunbar, Peter Forsyth, Edina Komlodi-Pasztor, Jacob Mandel, Byram H. Ozer, Eudocia Q. Lee, Surabhi Ranjan, Rimas V. Lukas, Margarita Raygada, Michael E. Salacz, Matthew A. Smith-Cohn, James Snyder, Ariane Soldatos, Brett J. Theeler, Brigitte C. Widemann, Kevin A. Camphausen, John D. Heiss, Terri S. Armstrong, Mark R. Gilbert, Marta Penas-Prado

  • March 1, 2024

Related Content

Patterns of failure following stereotactic radiosurgery salvage for recurrent high-grade glioma

Dana Farber/Boston Children’s Researchers Uncover Distinct Tumor “neighborhoods” with Each Cell Subtype Playing a Specific Role, in Aggressive Childhood Brain Cancer

Their detailed blueprint of tumor cell diversity could guide more precise, targeted treatments for supratentorial ependymomas 

  • by

  • March 12, 2026

  • 3 min
Perioperative risk stratification after resection of brain metastases: internal development and validation of the dominant lesion surgery score in a 20-year single-center cohort